Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(29)
- Computing and Computational Sciences Directorate (39)
- Energy Science and Technology Directorate (229)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (138)
- User Facilities (28)
Researcher
- Daniel Jacobson
- Vlastimil Kunc
- Ahmed Hassen
- Brian Sanders
- Dan Coughlin
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jerry Parks
- Jim Tobin
- John F Cahill
- Josh Crabtree
- Josh Michener
- Kim Sitzlar
- Liangyu Qian
- Merlin Theodore
- Paul Abraham
- Steven Guzorek
- Subhabrata Saha
- Vilmos Kertesz
- Vipin Kumar
- Xiaohan Yang
- Yang Liu

Mechanism-Based Trait Inference in Plants Using Multiplex Networks, AI Agents, and Translation Tools
This system enables the modular design and optimization of complex plant traits by organizing genes and regulatory mechanisms into interpretable clades.

Mechanism-Based Biological Inference via Multiplex Networks, AI Agents and Cross-Species Translation
This invention provides a platform that uses AI agents and biological networks to uncover and interpret disease-relevant biological mechanisms.

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Through the use of splicing methods, joining two different fiber types in the tow stage of the process enables great benefits to the strength of the material change.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.